FDA approves expanded label for Namzaric in Alzheimer’s disease
The US Food and Drug Administration (FDA) has approved an expanded label for Namzaric.
Click on this link for more information.
top of page
bottom of page
The US Food and Drug Administration (FDA) has approved an expanded label for Namzaric.
Click on this link for more information.
